Search results for: 'pace pacif analysis for laboratory develop'
- Related search terms
- analysis of the north american radiology image and information management systemnorth american radiology pacs and (ris(ris pacs) market
- analysis-of-the-ethiopian-pharmaceutical-market.html
- analysis of the drug delivery devices market forecast to 2023
- pace 01 00 00 00
- pacif 01 00 00 00
-
28 Apr 2025  |  Global  |  Market Research
Neurovascular Surgical Devices Market, Global, 2025–2029
Technology Innovations Fueling Transformational Growth in Minimally Invasive Surgical Procedures
This study provides a detailed overview of the neurovascular surgical devices market, covering various aspects driving its growth. It examines the multiple devices used in neurovascular surgical procedures, including neurovascular stents, neurovascular embolization devices, neurovascular thrombectomy devices, and neurovascular catheters.The market ...
$4,950.00
Special Price $4,455.00 save 10 %
-
13 May 2025  |  Global  |  Market Research
Autonomous Vehicle Regulations, Global, 2024
Evolving Regulatory Frameworks and Strategic Innovations Pave the Way for Autonomous Vehicle Market Transformation
This study provides a strategic analysis of global autonomous vehicle (AV) regulations in 2024, highlighting key developments in testing across regions, regional dynamics, and frameworks shaping the AV ecosystem. It examines legislative progress and testing initiatives across North America, Europe, Asia-Pacific (APAC), and emerging markets. The US ...
$4,950.00
Special Price $4,455.00 save 10 %
-
06 Jul 2023  |  North America  |  Market Research
Latin American Hybrid and Electric Vehicles Growth Opportunities
Competitive Intensity Driven by the Entry of New Participants Stimulates Electrified Vehicle Sales
The electrified vehicle (xEV) industry in Latin America is at an emerging stage, in terms of vehicle sales, charging infrastructure, and regulations. However, it has been growing at a fast pace, primarily because of the entry of new models and the launch of purchase incentives. For example, in 2022, almost 157,000 electrified units were sold in the...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Nov 2025  |  North America  |  Frost Radar
Frost Radar™: North American UCaaS and Cloud-Connected Calling Service Providers, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ evaluates wireline and mobile telecommunications providers, managed service providers, internet service providers, value-added resellers, systems integrators, and other types of resellers of hosted IP telephony, cloud PBX, and/or UCaaS services. The size of a provider’s North American UCaaS installed base is the main metric that F...
$4,950.00 -
14 Jan 2026  |  Asia Pacific  |  Market Research
Managed and Professional Security Services Market, China, 2025–2030
Managed and Professional Security Services are Experiencing Transformational Growth due to Intensifying Cyber Threats and Expanding Digital Attack Surfaces
The scale and sophistication of cyberattacks in China continue to rise, driven by the rapid adoption of cloud computing, mobile applications, IoT devices, and industrial digitalization. Increasing automation of attacks, combined with wider use of AI-driven intrusion techniques, is placing unprecedented pressure on organizations to strengthen visibi...
$4,950.00 -
18 Apr 2022  |  North America  |  Market Research
Global Vaccine Growth Opportunities
Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally
Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Aug 2022  |  North America  |  Market Research
Global Antibody Therapeutics Growth Opportunities
The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth
Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...
$2,450.00
Special Price $1,837.50 save 25 %
-
24 Jul 2017  |  Global  |  Market Research
Aluminum (Al) Rods and Conductors Market in India, 2017
Conductors Market likely to grow on doubling energy demand
India’s expanding economy and population are the biggest drivers of energy demand. Universal access to electricity is one of the primary aims of the Government, which has launched multiple schemes to support Production, Transmission and Distribution of electricity. Electricity demand in India is growing at 13% per annum, whereas its connection grid...
$1,500.00
Special Price $1,125.00 save 25 %
-
23 Jun 2021  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00
Special Price $3,712.50 save 25 %